Mallinckrodt Pharmaceuticals
Mallinckrodt, which has its headquarters in Mulhuddart, Dublin 15 but operates from its location in Missouri in the US, is a global specialty biopharmaceutical and medical imaging business that develops, manufactures, markets and distributes specialty pharmaceutical products and medical imaging agents. Mallinckrodt was spun-off by Covidien in 2013.
Financial Data
-
28th Dec 18 Source: CRO
- €2.9 billion turnover
-
-€3.6 billion
profit - 3,517 employees
-
29th Dec 17 Source: Company
- €3.3 billion turnover
-
-€135 million
profit - 4,089 employees
- 2 more years available »
Ranking
By Turnover
(€2.9 billion)- 43rd in Top Companies
By Employees
(3,517)- 71st in Top Companies
- 3,517
- €2.9 billion
Employees
- David Keenan Vice President}
Latest News
- 9:19pm Irish tech firm to facilitate cashless tickets for hurling and football
- 7:52pm Dublin Port expects full-year volumes to be back at 2016 levels
- 6:19pm Business ‘will not survive’ on essential-only travel - task force
- 5:59pm Upbeat economic data helps European shares snap 3-day losing run
- 5:59pm Upbeat economic data helps European markets snap three-day losing run